Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

163
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
163
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

264
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
264
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

151
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
151
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

3.9K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Frailty Assessment Based on Multidimensional Physical Frailty Parameters Using Unsupervised Clustering in Respiratory Diseases: A Pilot Study.

Journal of clinical medicine·2026
Same author

Geographical origin classification of milk using six-year stable isotope and multi-element fingerprints with SHAP-based model interpretation.

Food chemistry·2026
Same author

Optimizing preoperative planning for total hip arthroplasty using random forest models to predict stem size and compatibility.

BMC musculoskeletal disorders·2026
Same author

Heterogeneous pathways to depressive and anxiety disorders: A cluster-based predictive study in a nationwide longitudinal cohort.

Psychological medicine·2026
Same author

Odor-specific olfactory stimulation is associated with selective transcriptional changes and partial improvement of stress-evoked bladder overactivity in mice.

Frontiers in neuroscience·2026
Same author

Creating an engine of scientific discovery, an Indo-Japan perspective: learnings from IJNTC 2025 workshop.

NPJ systems biology and applications·2026

Related Experiment Video

Updated: May 6, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.8K

Toward an integrated software platform for systems pharmacology.

Samik Ghosh, Yukiko Matsuoka, Yoshiyuki Asai

    Biopharmaceutics & Drug Disposition
    |October 24, 2013
    PubMed
    Summary

    Computational tools are essential for understanding complex biological systems, especially in systems pharmacology. An integrated software platform is crucial for advancing drug action and interaction modeling in biological research.

    More Related Videos

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Mapping Dysfunctional Protein-Protein Interactions in Disease
    09:39

    Mapping Dysfunctional Protein-Protein Interactions in Disease

    Published on: October 24, 2025

    1.2K

    Related Experiment Videos

    Last Updated: May 6, 2026

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    4.8K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    Mapping Dysfunctional Protein-Protein Interactions in Disease
    09:39

    Mapping Dysfunctional Protein-Protein Interactions in Disease

    Published on: October 24, 2025

    1.2K

    Area of Science:

    • Computational biology
    • Systems pharmacology
    • Bioinformatics

    Background:

    • Understanding complex biological systems necessitates advanced computational tools.
    • Systems pharmacology specifically requires computational approaches to analyze drug actions and interactions within a biological system.
    • Computational models serve as explicit representations of biological hypotheses for testing.

    Purpose of the Study:

    • To highlight the critical role of computational tools in systems pharmacology.
    • To emphasize the importance of computational models in representing and testing biological hypotheses.
    • To advocate for the development of integrated software platforms in the field.

    Main Methods:

    • Review of existing software and data resources for computational model development.
    • Analysis of the role of software platforms in biological research creativity and productivity.
    • Discussion of model verification and exploration of biological system behaviors.

    Main Results:

    • Computational models are vital for testing biological hypotheses in systems pharmacology.
    • Existing software and data resources support model development and analysis.
    • Software platforms significantly enhance productivity and creativity in biological research.

    Conclusions:

    • Integrated software platforms represent the next essential advancement for systems pharmacology.
    • Computational modeling is indispensable for dissecting complex biological systems and drug interactions.
    • Further development of integrated computational tools will accelerate biological discovery.